CEO 20 years of experience in biotechnology, venture capital and healthcare management consulting. Previously President of Poseida Therapeutics, Chief Financial Officer and Vice President, Finance and Strategy at Ligand Pharmaceuticals, Inc., Principal at private equity firm Warburg Pincus LLC, and Engagement Manager at McKinsey & Company.
President and Founder Inventor of the Rivelin® technology and co-founder of Dermtreat A/S. Previously VP R&D, Dumex-Alpharma, adjunct professor in physical-chemistry – Copenhagen University, VP Pharmaceutical Research and Development and cVP New Products, LEO Pharma. Has brought 7 products to market in USA, Europe and Japan.
Private investor having developed and worked with a number of SMEs – including funding, operations and exit. Previously experienced from large listed companies (AP Moller, FLSmidth and IC Companys), including positions as Group Treasurer and CFO.